⚙️ AI Hardware

EIRION's GNN Jumps Tox21 AUC from 0.75 to Context-Aware Heights

Drug models stalled at 0.7517 AUC because they treated molecules like solo acts. EIRION's graph neural network stages the full biological drama, promising fewer trial flops.

Biological knowledge graph connecting compounds, genes, and pathways for EIRION's GNN toxicity model

⚡ Key Takeaways

  • Random Forest baselines hit 0.7517 AUC on Tox21 but miss biological context like gene-pathway interactions.
  • EIRION's GATv2 graph neural net models compounds, genes, and pathways together for sharper toxicity predictions.
  • Potential to slash pharma's $50B annual trial failures—game-on for AI in drug discovery.

🧠 What's your take on this?

Cast your vote and see what theAIcatchup readers think

Elena Vasquez
Written by

Elena Vasquez

Senior editor at theAIcatchup. Generalist covering the biggest AI stories with a sharp, skeptical eye.

Worth sharing?

Get the best AI stories of the week in your inbox — no noise, no spam.

Originally reported by Towards AI

Stay in the loop

The week's most important stories from theAIcatchup, delivered once a week.